The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

While Ozempic has gained global popularity for treating type-2 diabetes and consequently triggering weight loss, many are now ...

“Faster-acting drugs have a higher abuse potential,” said DiFeliceantonio. “They have a different impact on the brain. So if ...

Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

About valuation, the current forward P/E is 13, but that number only looks cheap because earnings are at an unsustainably ...

Tim Seymour, Seymour Asset Management CIO, said in a recent program on CNBC that markets remain worried about AI valuations ...

A WOMAN who turned to “skinny jabs” to achieve her dream body has revealed how she’s been left with “clumps” of hair loss and ...

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

North Carolina clinics first noted weight loss from GLP‑1 diabetes drugs in 2016. GLP‑1 medicines suppress appetite and triggered a national obesity drug boom. Manufacturing race in North Carolina ...